Publications by authors named "Einat Bar-Sever"
Leuk Lymphoma
December 2021
Article Synopsis
- A study on late onset neutropenia (LON) after obinutuzumab treatment found it occurs similarly to LON after rituximab therapy, with rates of 23% and 21%, respectively.
- Patients with chronic lymphocytic leukemia (CLL) and post-transplantation lymphoproliferative disease (PTLD) showed a higher risk of developing LON.
- Febrile neutropenia, a severe complication of LON, was rare, affecting only 4.5% of patients and indicating that both treatments have comparable safety profiles regarding this complication.
